COMFORT SYSTEMS USA INC

FIX

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Driehaus Capital Eventide Asset Management

AI Signal

AI analyst context — unlock full analysis

Position Trend

Feb 13, 2026

$7.8M

1 fund

Feb 17, 2026

$37.8M

1 fund

+385% total institutional value over 2 quarters

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 40,482Value: $37.8M

# Signal Note: Driehaus Capital Initiates FIX Position **Note:** Comfort Systems USA (FIX) is a mechanical services contractor, not a biotech company—this appears to be a data error or portfolio diversification move unrelated to drug development. Driehaus's $37.8M entry suggests conviction in either operational improvements, M&A catalysts, or valuation recovery in the HVAC/mechanical services sector, but this signal has no bearing on biotech fundamentals or clinical pipelines.

Eventide Asset ManagementNEWFeb 13, 2026

More FIX Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

AXON2 funds NVDA2 funds VEEV2 funds VCYT2 funds LBRT2 funds RMBS2 funds UNP2 funds LITE

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief:

**Signal Note: Eventide Initiates FIX Position** Comfort Systems USA (FIX) is an HVAC and mechanical services contractor, not a biotech company—this appears to be a portfolio diversification move by Eventide rather than a biotech-specific signal. The $7.8M position (8,343 shares at ~$936/share) suggests Eventide may be deploying capital into industrial/infrastructure exposure, potentially reflecting conviction in commercial building services demand or ESG-aligned facility management trends.